Bulgecin A: The Key to a Broad‐Spectrum Inhibitor  That Targets Lytic Transglycosylases

What is it about?

Bulgecin A restores the usefulness of β-lactam antibiotics in resistant strains of Neisseria meningitidis and Neisseria gonorrhoeae. This is relevant for N. gonorrhoeae where no vaccines are available. This work illustrates how best to target dangerous pathogens using a multiple drug target approach, a new and alternative approach to fighting antibiotic resistance

Featured Image

Why is it important?

This work is particularly relevant for N. gonorrhoeae where no vaccines are available. Our study illustrates how best to target dangerous pathogens using a multiple drug target approach, a new and alternative approach to fighting antibiotic resistance